| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35220-10ug | |||
| Carrier-Free | NBP2-35220-1mg | |||
| Carrier-Free | NBP2-35220-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35024-10ug | |||
| Carrier-Free | NBP2-35024-1mg | |||
| Carrier-Free | NBP2-35024-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35307-10ug | |||
| Carrier-Free | NBP2-35307-1000ug | |||
| Carrier-Free | NBP2-35307-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-12016-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-12035-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35228-10ug | |||
| Carrier-Free | NBP2-35228-1mg | |||
| Carrier-Free | NBP2-35228-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35288-10ug | |||
| Carrier-Free | NBP2-35288-1mg | |||
| Carrier-Free | NBP2-35288-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-34912-10ug | |||
| Carrier-Free | NBP2-34912-1mg | |||
| Carrier-Free | NBP2-34912-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-09003-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-50136-0.025ml | |||
![Western Blot: BP1 Antibody [NBP3-10329] - Western blot analysis using NBP3-10329 on Human Lung as a positive control. Antibody Titration: 0.2-1 ug/ml](http://images.novusbio.com/fullsize/BP1-Antibody-Western-Blot-NBP3-10329-img0001.jpg "Western Blot: BP1 Antibody [NBP3-10329] - Western blot analysis using NBP3-10329 on Human Lung as a positive control. Antibody Titration: 0.2-1 ug/ml")
![Western Blot: CIITA Antibody [NBP3-10468] - Western blot analysis using NBP3-10468 on Human Liver as a positive control. Antibody Titration: 0.2-1 ug/ml](http://images.novusbio.com/fullsize/CIITA-Antibody-Western-Blot-NBP3-10468-img0001.jpg "Western Blot: CIITA Antibody [NBP3-10468] - Western blot analysis using NBP3-10468 on Human Liver as a positive control. Antibody Titration: 0.2-1 ug/ml")
![SDS-Page: Recombinant Rat IL-13 Protein [NBP2-35220]](http://images.novusbio.com/fullsize/Recombinant-Rat-IL-13-Protein-SDS-Page-NBP2-35220-img0002.jpg "SDS-Page: Recombinant Rat IL-13 Protein [NBP2-35220]")
![SDS-Page: Recombinant Human IL-13 Variant Protein [NBP2-35024]](http://images.novusbio.com/fullsize/Recombinant-Human-IL-13-Variant-Protein-SDS-Page-NBP2-35024-img0002.jpg "SDS-Page: Recombinant Human IL-13 Variant Protein [NBP2-35024]")
![SDS-Page: Primate IL-1 beta/IL-1F2 Protein [NBP2-35307]](http://images.novusbio.com/fullsize/Primate-IL-1-beta-IL-1F2-Protein-SDS-Page-NBP2-35307-img0001.jpg "SDS-Page: Primate IL-1 beta/IL-1F2 Protein [NBP2-35307]")
![Immunocytochemistry/Immunofluorescence: CD40 Ligand/TNFSF5 Antibody (IDEC-131 (Toralizumab)) - Chimeric [NBP3-12016] - Immunofluorescence analysis of paraformaldehyde fixed Jurkat cells on Shi-fix(TM) coverslips stained with the chimeric rabbit IgG version of IDEC-131 (Toralizumab) (NBP3-12016) at 10 ug/ml for 1h followed by Alexa Fluor(R) 488 secondary antibody (2 ug/ml), showing membrane staining. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP3-12016, DAPI, merged channels and an isotype control. The isotype control was an unknown specificity antibody followed by staining with Alexa Fluor(R) 488 secondary antibody.](http://images.novusbio.com/fullsize/CD40-Ligand-TNFSF5-Antibody-IDEC-131-Toralizumab-Chimeric-Immunocytochemistry-Immunofluorescence-NBP3-12016-img0001.jpg "Immunocytochemistry/Immunofluorescence: CD40 Ligand/TNFSF5 Antibody (IDEC-131 (Toralizumab)) - Chimeric [NBP3-12016] - Immunofluorescence analysis of paraformaldehyde fixed Jurkat cells on Shi-fix(TM) coverslips stained with the chimeric rabbit IgG version of IDEC-131 (Toralizumab) (NBP3-12016) at 10 ug/ml for 1h followed by Alexa Fluor(R) 488 secondary antibody (2 ug/ml), showing membrane staining. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP3-12016, DAPI, merged channels and an isotype control. The isotype control was an unknown specificity antibody followed by staining with Alexa Fluor(R) 488 secondary antibody.")
![Flow Cytometry: IL-17/IL-17A Antibody (MM17F3) - Chimeric [NBP3-12035] - Mouse splenocytes were stimulated with PMA and Ionomycin in presence of Monensin for 4 hours. The cells were fixed using 2% PFA, permeabilized using 0.5% Triton and stained with anti-Fluorescein IgG antibody (4-4-20; isotype control, black line) or the rabbit IgG version of MM17F3 (NBP3-12035, blue line) at a dilution of 1:100 for 1h at RT. After washing, bound antibody was detected using a goat anti-mouse IgG AlexaFluor(R) 488 antibody at a dilution of 1:1000 and cells were analyzed using a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/IL-17-IL-17A-Antibody-MM17F3-Chimeric-Flow-Cytometry-NBP3-12035-img0001.jpg "Flow Cytometry: IL-17/IL-17A Antibody (MM17F3) - Chimeric [NBP3-12035] - Mouse splenocytes were stimulated with PMA and Ionomycin in presence of Monensin for 4 hours. The cells were fixed using 2% PFA, permeabilized using 0.5% Triton and stained with anti-Fluorescein IgG antibody (4-4-20; isotype control, black line) or the rabbit IgG version of MM17F3 (NBP3-12035, blue line) at a dilution of 1:100 for 1h at RT. After washing, bound antibody was detected using a goat anti-mouse IgG AlexaFluor(R) 488 antibody at a dilution of 1:1000 and cells were analyzed using a FACSCanto flow-cytometer.")
![SDS-Page: Porcine IL-1 beta/IL-1F2 Protein [NBP2-35228]](http://images.novusbio.com/fullsize/Porcine-IL-1-beta-IL-1F2-Protein-SDS-Page-NBP2-35228-img0001.jpg "SDS-Page: Porcine IL-1 beta/IL-1F2 Protein [NBP2-35228]")
![SDS-Page: Rat SCF/c-kit Ligand Protein [NBP2-35288]](http://images.novusbio.com/fullsize/Rat-SCF-c-kit-Ligand-Protein-SDS-Page-NBP2-35288-img0001.jpg "SDS-Page: Rat SCF/c-kit Ligand Protein [NBP2-35288]")
![SDS-Page: Canine SCF/c-kit Ligand Protein [NBP2-34912]](http://images.novusbio.com/fullsize/Canine-SCF-c-kit-Ligand-Protein-SDS-Page-NBP2-34912-img0001.jpg "SDS-Page: Canine SCF/c-kit Ligand Protein [NBP2-34912]")
![Immunocytochemistry/Immunofluorescence: Adenosine A2aR Antibody (Ig2838) - Chimeric [NBP3-09003] - Immunofluorescence analysis of paraformaldehyde fixed HepG2 cells on Shi-fix(TM) coverslips, permeabilized with 0.15% Triton and stained with the chimeric mouse IgG1 version of Ig2838 (NBP3-09003) at 10 ug/ml for 1h followed by Alexa Fluor(R) 488 secondary antibody (2 ug/ml), showing granular cytoplasmic staining, possibly of protein in trafficking vesicles. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP3-09003, DAPI, merged channels and an isotype control. The isotype control was stained with an unknown specificity antibody followed by Alexa Fluor(R) 488 secondary antibody.](http://images.novusbio.com/fullsize/Adenosine-A2aR-Antibody-Ig2838-Chimeric-Immunocytochemistry-Immunofluorescence-NBP3-09003-img0001.jpg "Immunocytochemistry/Immunofluorescence: Adenosine A2aR Antibody (Ig2838) - Chimeric [NBP3-09003] - Immunofluorescence analysis of paraformaldehyde fixed HepG2 cells on Shi-fix(TM) coverslips, permeabilized with 0.15% Triton and stained with the chimeric mouse IgG1 version of Ig2838 (NBP3-09003) at 10 ug/ml for 1h followed by Alexa Fluor(R) 488 secondary antibody (2 ug/ml), showing granular cytoplasmic staining, possibly of protein in trafficking vesicles. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP3-09003, DAPI, merged channels and an isotype control. The isotype control was stained with an unknown specificity antibody followed by Alexa Fluor(R) 488 secondary antibody.")